GlassScriptPhysician profile
Shelly Dueber
NPI 1982786968
$989.06
in general payments reported to CMS, 2019-2025
19 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $157 · 2021: $408 · 2022: $74.33 · 2024: $54.41 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $234.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $178.63 | 2019-2021 | |
| Abbvie INC. | $70.91 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $48.33 | 2020-2021 | |
| Pfizer INC. | $46.73 | 2022-2025 | |
| Lilly USA, LLC | $46.70 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.45 | 2024-2025 | |
| Novo Nordisk INC | $40.07 | 2019 | |
| Sunovion Pharmaceuticals INC. | $39.57 | 2019-2020 | |
| Bausch Health US, LLC | $38.85 | 2025 | Aplenzin |
| Astellas Pharma US INC | $33.32 | 2020 | |
| Amgen INC. | $30.11 | 2024 | Repatha, Otezla |
| Eisai INC. | $23.33 | 2021 | |
| Mylan Specialty L.P. | $22.64 | 2019 | |
| Resmed Corp | $20.86 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qiagen, LLC | $17.95 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.95 | 2020 | |
| Paratek Pharmaceuticals, INC. | $16.93 | 2025 | Nuzyra |
| Edwards Lifesciences Corporation | $15.91 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Dueber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.